ask="N/A"
ask_size="N/A"
average_daily_volume="1120920"
bid="N/A"
bid_size="N/A"
book_value="-0.153"
change="-0.001"
change_from_200_day_moving_average="-0.080"
change_from_50_day_moving_average="0.017"
change_from_52_week_high="-1.411"
change_From_52_week_low="0.241"
change_in_percent="-0.209%"
close="0.429"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.654"
ebitda="-18.11M"
eps_estimate_current_year="-0.550"
eps_estimate_next_quarter="-0.090"
eps_estimate_next_year="-0.450"
ex_dividend_date="N/A"
float_shares="43543000"
high="0.445"
high_52_weeks="1.840"
last_trade_date="1/24/2017"
last_trade_price="0.429"
last_trade_size="100"
last_trade_time="4:02pm"
low="0.421"
low_52_weeks="0.188"
market_capitalization="29.05M"
moving_average_200_day="0.509"
moving_average_50_day="0.412"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.000"
open="0.435"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="-15.745%"
percent_change_from_50_day_moving_average="+4.057%"
percent_change_from_52_week_high="-76.685%"
percent_change_from_52_week_low="+128.191%"
previous_close="0.430"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="242.605"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="0.750"
stock_exchange="ASE"
symbol="BPMX"
volume="647585"
weeks_range_52="0.188 - 1.840"
